The Claim
β-Casomorphin-7 at a concentration of 10⁻⁴ M increases mucin secretion by 169–227% and upregulates expression of rMuc2, rMuc3 in rat intestinal goblet cell lines and MUC5AC in human intestinal goblet cell lines within 2–24 hours, and this effect is blocked by the μ-opioid antagonist cyprodime, indicating that activation of μ-opioid receptors on epithelial cells directly drives mucin production.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
β-Casomorphin-7 at a specific concentration increases mucin secretion and activates mucin gene expression in human and rat intestinal cells within hours, and this effect is prevented by a drug that blocks μ-opioid receptors.
See the scientific wording
β-Casomorphin-7 at a concentration of 10⁻⁴ M increases mucin secretion by 169–227% and upregulates expression of specific mucin genes (rMuc2, rMuc3 in rat cells; MUC5AC in human cells) within 2–24 hours in intestinal goblet cell lines, an effect blocked by the μ-opioid antagonist cyprodime, indicating direct activation of μ-opioid receptors on epithelial cells drives mucin production.
A peptide from milk binds to special receptors on gut mucus-producing cells, turning on genes that make protective mucus proteins and causing the cells to release those proteins into the gut lining.
What the research says
1 studyA milk-derived peptide called β-casomorphin-7 was shown to make gut cells produce more protective mucus by turning on a specific receptor (μ-opioid), and this effect was blocked when the receptor was turned off — proving it works directly as claimed.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.